Prostate Cancer Community Assistance, Research and Education Act of 2022

Prostate Cancer Community Assistance, Research and Education Act of 2022 or the PC-CARE Act

This bill establishes a committee to develop, implement, and periodically revise a plan to coordinate federal activities and programs concerning prostate cancer, including those related to research, screening, diagnosis, and treatment.

Committee members must include representatives from specified federal agencies, as well as researchers, clinicians, individuals living with prostate cancer (or their caregivers), and other stakeholders. In addition, at least half of the members must be physicians.

Bill 117 HR 7750, also known as the Prostate Cancer Community Assistance, Research and Education Act of 2022, is a piece of legislation introduced in the US Congress with the aim of providing support and resources for individuals affected by prostate cancer. The bill seeks to improve access to information, treatment, and support services for those diagnosed with prostate cancer, as well as to promote research and education in the field.

Key provisions of the bill include the establishment of a Prostate Cancer Community Assistance Program, which would provide grants to organizations that offer support services to individuals with prostate cancer and their families. The bill also calls for the creation of a Prostate Cancer Research Consortium, which would facilitate collaboration among researchers and healthcare providers to advance the understanding and treatment of prostate cancer.

Additionally, the bill includes provisions to increase funding for prostate cancer research and education programs, as well as to improve access to screening and early detection services. The bill also aims to raise awareness about the importance of prostate cancer screening and treatment, particularly among high-risk populations. Overall, Bill 117 HR 7750 represents a bipartisan effort to address the challenges faced by individuals with prostate cancer and to improve outcomes for those affected by this disease. If passed, the bill has the potential to make a significant impact on the lives of individuals and families impacted by prostate cancer.